CN Stock MarketDetailed Quotes

603882 Guangzhou Kingmed Diagnostics Group

Watchlist
  • 38.10
  • -4.05-9.61%
Market Closed Apr 26 15:00 CST
17.86BMarket Cap37.57P/E (TTM)

Guangzhou Kingmed Diagnostics Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-13.05%1.84B
-44.82%8.54B
-48.32%6.31B
-48.17%4.31B
-50.19%2.12B
29.58%15.48B
41.67%12.21B
52.37%8.31B
58.70%4.25B
44.88%11.94B
Operating revenue
-13.05%1.84B
-44.82%8.54B
-48.32%6.31B
-48.17%4.31B
-50.19%2.12B
29.58%15.48B
41.67%12.21B
52.37%8.31B
58.70%4.25B
44.88%11.94B
Other operating revenue
----
-14.08%813.43M
----
-4.59%419.63M
----
48.04%946.76M
----
73.55%439.83M
----
71.01%639.52M
Total operating cost
-4.52%1.74B
-36.07%7.64B
-38.66%5.58B
-40.65%3.68B
-41.88%1.82B
30.40%11.94B
38.44%9.09B
47.79%6.19B
54.92%3.13B
42.44%9.16B
Operating cost
-4.88%1.25B
-38.37%5.42B
-41.40%3.95B
-42.64%2.64B
-42.41%1.31B
39.82%8.8B
46.46%6.74B
57.16%4.6B
61.09%2.28B
43.23%6.3B
Operating tax surcharges
13.56%4.09M
1.09%14.91M
0.40%10.71M
1.78%6.91M
3.86%3.6M
25.98%14.75M
31.52%10.67M
29.26%6.79M
39.61%3.47M
68.86%11.71M
Operating expense
-0.81%231.58M
-32.79%1.02B
-34.71%737.74M
-37.02%483.67M
-44.82%233.48M
5.22%1.51B
14.70%1.13B
22.25%767.99M
39.20%423.14M
45.00%1.44B
Administration expense
16.34%161.17M
-28.22%714.61M
-31.80%515.68M
-42.82%295.72M
-50.24%138.53M
12.12%995.53M
25.33%756.09M
29.03%517.18M
46.03%278.39M
42.61%887.95M
Financial expense
30.16%-312.55K
91.61%-1.05M
-38.56%-1.14M
-1,338.72%-1.79M
-111.74%-447.53K
-224.58%-12.57M
-110.62%-824.94K
-102.21%-124.57K
77.14%3.81M
-42.52%10.09M
-Interest expense (Financial expense)
-9.46%4.91M
-13.79%20.39M
-11.30%15.29M
-5.42%10.87M
-4.64%5.42M
-14.14%23.65M
-16.09%17.23M
-16.39%11.5M
-20.64%5.69M
-5.84%27.55M
-Interest Income (Financial expense)
24.03%-5.8M
16.47%-25.39M
14.43%-19.8M
2.52%-15.4M
-0.61%-7.63M
-41.16%-30.4M
-45.40%-23.14M
-47.80%-15.8M
-36.05%-7.59M
-56.49%-21.53M
Research and development
-30.02%92.12M
-26.16%467.14M
-20.07%365.47M
-16.33%254.21M
-7.36%131.64M
22.14%632.62M
26.31%457.25M
34.94%303.81M
33.54%142.11M
30.40%517.93M
Credit Impairment Loss
5.58%-139.5M
-90.74%-488.54M
-128.64%-392.3M
-196.55%-317.46M
-170.40%-147.73M
-263.31%-256.13M
-205.01%-171.58M
-374.69%-107.05M
-559.36%-54.64M
-52.51%-70.5M
Asset Impairment Loss
-1,998.45%-242.87K
123.52%519.05K
172.17%546.56K
184.58%290.87K
103.28%12.79K
144.74%232.21K
-26.07%-757.35K
38.75%-343.88K
35.82%-389.99K
40.96%-518.98K
Other net revenue
3.40%-127.18M
22.48%-144.63M
23.31%-91.51M
-355.14%-295.59M
-210.18%-131.67M
-2,137.24%-186.58M
-1,262.69%-119.33M
-678.72%-64.95M
-111,657.74%-42.45M
-436.82%-8.34M
Invest income
48.39%-2.38M
2,534.98%262.97M
3,861.60%262.15M
-151.87%-7.13M
-1,119.42%-4.61M
-48.04%-10.8M
-24.79%-6.97M
35.20%-2.83M
86.10%-378.26K
60.92%-7.29M
-Including: Investment income associates
48.39%-2.38M
25.69%-9.81M
-4.32%-9.78M
-36.07%-7.13M
-73.70%-4.61M
-49.27%-13.21M
-31.36%-9.38M
-5.93%-5.24M
2.39%-2.66M
52.66%-8.85M
Asset deal income
50,188.54%3.29M
-44.89%2.2M
-71.66%599.17K
-89.45%74.47K
-100.93%-6.57K
141.00%3.99M
47.86%2.11M
294.42%705.84K
1.85%705.65K
-562.52%-9.74M
Other revenue
-43.68%11.64M
2.75%78.22M
-35.21%37.49M
-35.77%28.63M
68.77%20.67M
-4.50%76.13M
10.74%57.87M
15.71%44.57M
12.55%12.25M
20.52%79.71M
Operating profit
-115.22%-25.02M
-77.30%759.76M
-78.58%642.42M
-83.62%336.31M
-84.71%164.44M
20.54%3.35B
46.82%3B
60.98%2.05B
63.90%1.08B
52.83%2.78B
Add:Non operating Income
30.65%801.07K
79.70%3.78M
41.59%2.71M
-6.26%1.84M
-36.11%613.13K
6.31%2.1M
36.75%1.92M
97.44%1.96M
42.27%959.69K
-8.88%1.98M
Less:Non operating expense
-66.79%2.59M
-18.71%23.26M
-24.50%17.96M
433.63%12.22M
1,802.86%7.79M
-8.27%28.61M
-4.74%23.79M
-39.14%2.29M
-82.27%409.19K
264.18%31.19M
Total profit
-117.04%-26.81M
-77.71%740.29M
-78.93%627.16M
-84.12%325.93M
-85.38%157.27M
20.86%3.32B
47.45%2.98B
61.30%2.05B
64.40%1.08B
51.76%2.75B
Less:Income tax cost
-102.32%-386.53K
-78.27%103.38M
-86.31%60.51M
-86.32%43.69M
-89.99%16.65M
23.87%475.72M
61.94%442.04M
88.65%319.37M
64.73%166.26M
62.02%384.05M
Net profit
SL-26.42M
-77.61%636.91M
-77.65%566.65M
-83.72%282.24M
-84.54%140.62M
20.37%2.85B
45.18%2.54B
57.10%1.73B
64.34%909.42M
50.21%2.36B
Net profit from continuing operation
-118.79%-26.42M
-77.61%636.91M
-77.65%566.65M
-83.72%282.24M
-84.54%140.62M
20.37%2.85B
45.18%2.54B
57.10%1.73B
64.34%909.42M
50.21%2.36B
Less:Minority Profit
13.49%-7.78M
-107.18%-6.47M
-110.79%-9.37M
-102.88%-2.61M
-115.18%-9M
-37.29%90.22M
17.35%86.81M
105.03%90.42M
287.12%59.25M
125.75%143.87M
Net profit of parent company owners
-112.46%-18.64M
-76.64%643.38M
-76.47%576.02M
-82.66%284.84M
-82.40%149.61M
24.11%2.75B
46.41%2.45B
55.11%1.64B
58.00%850.17M
47.03%2.22B
Earning per share
Basic earning per share
-112.50%-0.04
-76.65%1.38
-76.57%1.23
-82.72%0.61
-82.51%0.32
23.13%5.91
45.83%5.25
53.48%3.53
57.76%1.83
45.90%4.8
Diluted earning per share
-112.50%-0.04
-76.61%1.38
-76.53%1.23
-82.62%0.61
-82.42%0.32
23.95%5.9
46.78%5.24
54.63%3.51
56.90%1.82
45.57%4.76
Other composite income
100.54%80.54K
-73.19%7.99M
-70.76%15.24M
-40.86%13.27M
-1,347.62%-14.87M
398.02%29.81M
8,700.10%52.13M
1,828.39%22.44M
-147.36%-1.03M
-181.08%-10M
Other composite income of parent company owners
100.54%80.54K
-73.19%7.99M
-70.76%15.24M
-40.86%13.27M
-1,347.62%-14.87M
398.02%29.81M
8,700.10%52.13M
1,828.39%22.44M
-147.36%-1.03M
-181.08%-10M
Total composite income
-120.95%-26.34M
-77.57%644.9M
-77.51%581.89M
-83.17%295.51M
-86.16%125.75M
22.15%2.87B
48.22%2.59B
59.33%1.76B
63.51%908.4M
49.92%2.35B
Total composite income of parent company owners
-113.77%-18.56M
-76.61%651.37M
-76.35%591.26M
-82.10%298.12M
-84.13%134.74M
26.02%2.78B
49.58%2.5B
57.42%1.67B
57.17%849.15M
46.71%2.21B
Total composite income of minority owners
13.49%-7.78M
-107.18%-6.47M
-110.79%-9.37M
-102.88%-2.61M
-115.18%-9M
-37.29%90.22M
17.35%86.81M
105.03%90.42M
287.12%59.25M
125.75%143.87M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -13.05%1.84B-44.82%8.54B-48.32%6.31B-48.17%4.31B-50.19%2.12B29.58%15.48B41.67%12.21B52.37%8.31B58.70%4.25B44.88%11.94B
Operating revenue -13.05%1.84B-44.82%8.54B-48.32%6.31B-48.17%4.31B-50.19%2.12B29.58%15.48B41.67%12.21B52.37%8.31B58.70%4.25B44.88%11.94B
Other operating revenue -----14.08%813.43M-----4.59%419.63M----48.04%946.76M----73.55%439.83M----71.01%639.52M
Total operating cost -4.52%1.74B-36.07%7.64B-38.66%5.58B-40.65%3.68B-41.88%1.82B30.40%11.94B38.44%9.09B47.79%6.19B54.92%3.13B42.44%9.16B
Operating cost -4.88%1.25B-38.37%5.42B-41.40%3.95B-42.64%2.64B-42.41%1.31B39.82%8.8B46.46%6.74B57.16%4.6B61.09%2.28B43.23%6.3B
Operating tax surcharges 13.56%4.09M1.09%14.91M0.40%10.71M1.78%6.91M3.86%3.6M25.98%14.75M31.52%10.67M29.26%6.79M39.61%3.47M68.86%11.71M
Operating expense -0.81%231.58M-32.79%1.02B-34.71%737.74M-37.02%483.67M-44.82%233.48M5.22%1.51B14.70%1.13B22.25%767.99M39.20%423.14M45.00%1.44B
Administration expense 16.34%161.17M-28.22%714.61M-31.80%515.68M-42.82%295.72M-50.24%138.53M12.12%995.53M25.33%756.09M29.03%517.18M46.03%278.39M42.61%887.95M
Financial expense 30.16%-312.55K91.61%-1.05M-38.56%-1.14M-1,338.72%-1.79M-111.74%-447.53K-224.58%-12.57M-110.62%-824.94K-102.21%-124.57K77.14%3.81M-42.52%10.09M
-Interest expense (Financial expense) -9.46%4.91M-13.79%20.39M-11.30%15.29M-5.42%10.87M-4.64%5.42M-14.14%23.65M-16.09%17.23M-16.39%11.5M-20.64%5.69M-5.84%27.55M
-Interest Income (Financial expense) 24.03%-5.8M16.47%-25.39M14.43%-19.8M2.52%-15.4M-0.61%-7.63M-41.16%-30.4M-45.40%-23.14M-47.80%-15.8M-36.05%-7.59M-56.49%-21.53M
Research and development -30.02%92.12M-26.16%467.14M-20.07%365.47M-16.33%254.21M-7.36%131.64M22.14%632.62M26.31%457.25M34.94%303.81M33.54%142.11M30.40%517.93M
Credit Impairment Loss 5.58%-139.5M-90.74%-488.54M-128.64%-392.3M-196.55%-317.46M-170.40%-147.73M-263.31%-256.13M-205.01%-171.58M-374.69%-107.05M-559.36%-54.64M-52.51%-70.5M
Asset Impairment Loss -1,998.45%-242.87K123.52%519.05K172.17%546.56K184.58%290.87K103.28%12.79K144.74%232.21K-26.07%-757.35K38.75%-343.88K35.82%-389.99K40.96%-518.98K
Other net revenue 3.40%-127.18M22.48%-144.63M23.31%-91.51M-355.14%-295.59M-210.18%-131.67M-2,137.24%-186.58M-1,262.69%-119.33M-678.72%-64.95M-111,657.74%-42.45M-436.82%-8.34M
Invest income 48.39%-2.38M2,534.98%262.97M3,861.60%262.15M-151.87%-7.13M-1,119.42%-4.61M-48.04%-10.8M-24.79%-6.97M35.20%-2.83M86.10%-378.26K60.92%-7.29M
-Including: Investment income associates 48.39%-2.38M25.69%-9.81M-4.32%-9.78M-36.07%-7.13M-73.70%-4.61M-49.27%-13.21M-31.36%-9.38M-5.93%-5.24M2.39%-2.66M52.66%-8.85M
Asset deal income 50,188.54%3.29M-44.89%2.2M-71.66%599.17K-89.45%74.47K-100.93%-6.57K141.00%3.99M47.86%2.11M294.42%705.84K1.85%705.65K-562.52%-9.74M
Other revenue -43.68%11.64M2.75%78.22M-35.21%37.49M-35.77%28.63M68.77%20.67M-4.50%76.13M10.74%57.87M15.71%44.57M12.55%12.25M20.52%79.71M
Operating profit -115.22%-25.02M-77.30%759.76M-78.58%642.42M-83.62%336.31M-84.71%164.44M20.54%3.35B46.82%3B60.98%2.05B63.90%1.08B52.83%2.78B
Add:Non operating Income 30.65%801.07K79.70%3.78M41.59%2.71M-6.26%1.84M-36.11%613.13K6.31%2.1M36.75%1.92M97.44%1.96M42.27%959.69K-8.88%1.98M
Less:Non operating expense -66.79%2.59M-18.71%23.26M-24.50%17.96M433.63%12.22M1,802.86%7.79M-8.27%28.61M-4.74%23.79M-39.14%2.29M-82.27%409.19K264.18%31.19M
Total profit -117.04%-26.81M-77.71%740.29M-78.93%627.16M-84.12%325.93M-85.38%157.27M20.86%3.32B47.45%2.98B61.30%2.05B64.40%1.08B51.76%2.75B
Less:Income tax cost -102.32%-386.53K-78.27%103.38M-86.31%60.51M-86.32%43.69M-89.99%16.65M23.87%475.72M61.94%442.04M88.65%319.37M64.73%166.26M62.02%384.05M
Net profit SL-26.42M-77.61%636.91M-77.65%566.65M-83.72%282.24M-84.54%140.62M20.37%2.85B45.18%2.54B57.10%1.73B64.34%909.42M50.21%2.36B
Net profit from continuing operation -118.79%-26.42M-77.61%636.91M-77.65%566.65M-83.72%282.24M-84.54%140.62M20.37%2.85B45.18%2.54B57.10%1.73B64.34%909.42M50.21%2.36B
Less:Minority Profit 13.49%-7.78M-107.18%-6.47M-110.79%-9.37M-102.88%-2.61M-115.18%-9M-37.29%90.22M17.35%86.81M105.03%90.42M287.12%59.25M125.75%143.87M
Net profit of parent company owners -112.46%-18.64M-76.64%643.38M-76.47%576.02M-82.66%284.84M-82.40%149.61M24.11%2.75B46.41%2.45B55.11%1.64B58.00%850.17M47.03%2.22B
Earning per share
Basic earning per share -112.50%-0.04-76.65%1.38-76.57%1.23-82.72%0.61-82.51%0.3223.13%5.9145.83%5.2553.48%3.5357.76%1.8345.90%4.8
Diluted earning per share -112.50%-0.04-76.61%1.38-76.53%1.23-82.62%0.61-82.42%0.3223.95%5.946.78%5.2454.63%3.5156.90%1.8245.57%4.76
Other composite income 100.54%80.54K-73.19%7.99M-70.76%15.24M-40.86%13.27M-1,347.62%-14.87M398.02%29.81M8,700.10%52.13M1,828.39%22.44M-147.36%-1.03M-181.08%-10M
Other composite income of parent company owners 100.54%80.54K-73.19%7.99M-70.76%15.24M-40.86%13.27M-1,347.62%-14.87M398.02%29.81M8,700.10%52.13M1,828.39%22.44M-147.36%-1.03M-181.08%-10M
Total composite income -120.95%-26.34M-77.57%644.9M-77.51%581.89M-83.17%295.51M-86.16%125.75M22.15%2.87B48.22%2.59B59.33%1.76B63.51%908.4M49.92%2.35B
Total composite income of parent company owners -113.77%-18.56M-76.61%651.37M-76.35%591.26M-82.10%298.12M-84.13%134.74M26.02%2.78B49.58%2.5B57.42%1.67B57.17%849.15M46.71%2.21B
Total composite income of minority owners 13.49%-7.78M-107.18%-6.47M-110.79%-9.37M-102.88%-2.61M-115.18%-9M-37.29%90.22M17.35%86.81M105.03%90.42M287.12%59.25M125.75%143.87M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg